Fintel reports that on November 13, 2025, BMO Capital initiated coverage of Privia Health Group (NasdaqGS:PRVA) with a ...

Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year ...

Investors in Privia Health Group Inc (Symbol: PRVA) saw new options become available this week, for the May 2026 expiration. One of the key inputs that goes into the price an option buyer is willing ...

PRVA is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of PRVA shares has decreased $0.10 since the market last closed. This is a 0.41% ...

Fintel reports that on November 13, 2025, JP Morgan maintained coverage of Privia Health Group (NasdaqGS:PRVA) with a Overweight recommendation. As of November 9, 2025, the average one-year price ...

Medicare represents a significant growth opportunity for PRVA's business model, particularly as Commercial members move into Medicare and MSSPs or fully capitated arrangements. The formation of new ...

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care. Privia Health (NASDAQ: PRVA) came out with quarterly earnings of $0.03 ...